Earnings per Share - Additional Information (Details) - shares |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Feb. 01, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
| Business Acquisition [Line Items] | |||||
| Participating securities (in shares) | 0 | 0 | 0 | 0 | |
| Anti-dilutive common stock equivalents (in shares) | 106,000,000 | 47,000,000 | 62,000,000 | 76,000,000 | |
| Common Stock | Pandora | |||||
| Business Acquisition [Line Items] | |||||
| Common stock issued (in shares) | 392,000,000 | 392,000,000 | |||
| X | ||||||||||
- Definition Participating securities. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|